Saving Seafood

Just How Healthy Is Salmon?

January 8, 2024 — Salmon is good for you — that part we know.

“Fish is one of the few animal foods consistently linked to health benefits, and salmon is at the top of my list when I recommend fish to people,” said Dr. Dariush Mozaffarian, a distinguished professor and the director of the Food is Medicine Institute at Tufts University.

But choosing which type to eat for your health — sockeye or coho, wild or farmed — isn’t so obvious. Researchers have found that the nutritional value of salmon can vary depending on the species. And there is a consumer perception that farmed and wild-caught salmon differ in terms of their nutrients and levels of contaminants — beliefs that research partly supports.

From healthy fats to heavy metals, here are answers to all your salmon-related questions.

Read the full article at The New York Times

Satellite Monitoring of Fishing Fleets: A Definitive Answer To Consumer Concerns About Sustainable Seafood.

November 5, 2021 — The following was released by Friend of the Sea:

Friend of the Sea, the leading international certification of sustainable seafood and Omega3, has developed its own enhanced platform based on satellite technology to monitor the over 2.000 Friend of the Sea approved fishing vessels.

The Friend of the Sea Satellite Monitoring Program (SMP) is part of a monitoring enhancement program, which includes among the others, deployment of CCTVs onboard, drones and unannounced augmented reality audit. These new technologies will eliminate the risk of non-compliance and further reassure consumers about the reliability of the Friend of the Sea certification.

By means of the SMP, vessels are monitored continuously 24 hours a day, 365 days per year. Satellite monitoring allows for verification of compliance with regulations related to fishing season; authorized fishing areas; transshipment at sea and Social Accountability.

“Consumers and retailers looking for a certification carrying out not only annual onsite inspections, but also full-time monitoring of fishing activities, can now rely on Friend of the Sea for a safer sustainable choice” explains Paolo Bray, Founder and Director of Friend of the Sea. 

“Satellite monitoring is an exclusivity of Friend of the Sea, making it the first and only certification monitoring each moment of the fishing activity, to protect the Oceans from unsustainable fishing. Our aim is to make sure that all industrial vessels approved Friend of the Sea will, by the end of 2023 have CCTVs on board to allow Friend of the Sea verification of compliance with issues related to bycatch, fishing methods, endangered species, fish welfare and social accountability. New technologies make Friend of the Sea the most reliable certification in the seafood market”.

Today’s DGAC Report Says Moms & Kids Need More Seafood

July 15, 2020 — The following was released by the Seafood Nutrition Partnership:

The 2020 Dietary Guidelines Advisory Committee (DGAC) released its final scientific report that will serve as the foundation for the development of the 2020-2025 Dietary Guidelines for Americans. The DGAC final report, comprised of 835 pages, has positive findings for seafood consumption.

  •  Seafood consumption before pregnancy may be related to reduced risk of gestational diabetes and hypertensive disorders.
  • Consumption during pregnancy may be related to reduced risk of hypertensive disorders and preterm birth and better cognitive development and language and communication development in children.
  • Women who are lactating should continue to consume seafood at the same amounts recommended during pregnancy.
  • Provide good sources of omega-3 and omega-6 fatty acids, such as seafood, beginning at ages 6 to 12 months, and prioritize seafood for toddlers ages 12 to 24 months.

Read the full release here

Recent studies say fish oil could boost your heart

November 16, 2018 — Heart disease is the leading killer in America, and San Antonio is no exception.

But as the Washington Post reports, two recent major studies point to the possibility that medications derived from fish oils could help protect people from heart attacks, strokes and other types of cardiovascular ailments. These are medications, not supplements.

The long-term studies involved two drugs derived from omega-3 fatty acids. Both studies found the drugs, if taken appropriately, made a significant difference for people with diabetes or heart disease.

Read the full story at the San Antonio Express

NEW JERSEY: Conflict boils over baitfish harvest off Sandy Hook

September 20, 2018 — A tug-of-war over menhaden baitfish has been playing out for the last half-dozen years in quiet library meeting rooms and hotel lobbies from Maine to Florida.

Now it’s taken to the high seas.

Twice in three weeks, a pair of industrial-size reduction boats from Reedsville, Virginia came within sight of Sandy Hook to net the bait, removing nearly 3 million pounds of the fish from the water on the two trips.

A sum equal to one-tenth of one percent of all the menhaden in the ocean.

The boats were within their legal right but a social media dust-up ensued with whale watchers and conservationists who homed their cameras in on the boats. See the above video.

They then blasted their pictures and videos on the web, clamoring the boats took the fish out of the mouths of hungry humpback whales.

“The simple sight of our vessels sets them off. They don’t say anything about the bait guys who take 70 million pounds of fish,” said Ben Landry, spokesman for Omega Protein, the company that owns the boats.

Omega Protein operates the lone fish reduction industry on the East Coast. The company’s name is a reference to menhaden’s rich source of Omega 3 fatty acids.

The company’s workforce is made up of multi-generational fishermen who have been harvesting the menhaden for years and raising their families on the fish.

But some want them to slow down, if not stop completely, and leave more menhaden in the water to feed big marine mammals like whales and game fish.

Menhaden, also known as bunker, play a vital role in the ecosystem as filter feeders that turn plankton into fat and protein.

Read the full story at the Asbury Park Press

Sustainable Omega 3 Consumption: A Positive Trend Set to Increase

September 5, 2018 — The following was released by Friend of the Sea:

The size of the global omega 3 supplement industry has grown enormously in recent years. Evidence from the market shows that more and more consumers worldwide are demanding fish oils and nutrients which are not only healthy and of high quality, but are also respectful of the marine environment. After decades of campaigns by environmental activists and enlightened industry operators, the message has finally reached a rising number of eco-conscious individuals and households globally.

Friend of the Sea Standard for Omega 3

Back in 2010, Friend of the Sea (FoS), an independent certification scheme set up two years earlier to assess the environmental sustainability associated with seafood from fisheries and aquaculture, felt the urgent need to introducing a specific standard for producers of fish oil, fishmeal, fish feed and omega-3 supplements. According to this, accredited third-party certification bodies certify that the oil originates only from fisheries are compliant with Friend of the Sea sustainable fishing requirements, including good fishery management, selective fishing gears and social responsibility, and that a full chain of custody is in place throughout the supply and the production chain.

The fish contained in certified omega 3 products can be traced back to certified fisheries which have been independently assessed to meet Friend of the Sea’s widely recognised standard for sustainable wild fishing. These fisheries are well managed and their impacts on the environment minimized so that seafood supplies are safeguarded for future generations.

The origin of certified fish oil

Today, 439 companies adhere voluntarily to Friend of the Sea standard for fish oil, fishmeal, fish feed and omega-3 supplement, an increase of around 477% compared with 2015 when there were only 76.

“As the leading globally recognised standard program for sustainable seafood, we are enthusiastic about scoring and sharing the positive change in attitude towards environmental sustainability and social accountability occurring also in the nutraceutical sector,” claims Paolo Bray, Founder and Director of Friend of the Sea. “Consumers worldwide can now have wider access to sustainable products on the shelves and we are convinced of an even brighter future for the sector.”

Certified oils originate mostly from approved Peruvian anchovy fisheries and fleet – Engraulis ringens – (29%), Antarctic krill – Euphausia superba – (22%), European sardine – Sardina pilchardus (8%), European anchovy – Engraulis encrasicolus – (7%), Chub mackerel – Scomber japonicus (7%), Atlantic cod – Gadus morhua – (3%). The remaining 24% derives from various species such as salmon, tuna and squid which are equally certified, processed and usually refined and blended.

Read the full release here

US fishmeal producers left exposed by China’s 25% tariff blow

August 16, 2018 — US fishmeal producers — including the US’ largest fishmeal producer Omega Protein — are “certainly in some trouble” after China announced last week it would impose 25% tariffs on imports from the country, said a fishmeal industry analyst.

Jean-Francois Mittaine, an analyst with 30 years’ experience in the sector, told Undercurrent News Omega Protein and others in the sector will struggle to find new markets as Chinese importers turn to alternative sources. This will hit both the menhaden fisheries of the Gulf of Mexico and the pollock fishmeal industry of Alaska.

“For the Americans it is a problem,” said Mittaine. “I don’t see what they’re going to do with their fishmeal.”

Last Wednesday, China’s Ministry of Commerce said it would impose an additional tariff on imports of US fishmeal of 25% (HS code 23012010). The ingredient used in animal and fish feed was among 333 US goods worth $16 billion in annual trade targeted.

The Chinese counter-move will take effect immediately after the US imposes tariffs on the same amount of Chinese goods on Aug 23.

Read the full story at Undercurrent News

For Infants With Rare And Scary Disorder, FDA Approval Of Fish Oil Could Be Life Saving

August 7, 2018 — The following is excerpted from a story published by WGBH:

The FDA approved a drug last month that provides nutrition to children born with a scary condition. That approval is the result of 16 years of work by doctors and researchers at Children’s Hospital in Boston.

When Gib Brogan’s daughter Ellie was born, he says at first everything seemed perfect. But things changed quickly.

“Soon after she was born, early, early one morning, she got very ill. She started vomiting dark green,” Brogan said.

Ellie was rushed to the neonatal ICU, where doctors quickly realized something was very wrong.

“They told us she had short bowel syndrome. She was missing 90 percent of her small intestine and 30 percent of her large intestine,” Brogan said.

The NIH says short bowel syndrome affects about three out of every million people. Ellie had surgery to connect her intestines, but there wasn’t enough there to really work right.

“On that first day the surgeon told us that she can be fed by I.V., but there is a bit of a race that comes when you feed an infant through an I.V.,” Brogan said.

That race is to get them eating regularly as soon as possible. Because while you can feed newborns through an I.V, over an extended period of time, the fat that they’re given, which comes from soybean oil, can damage their livers, meaning they’ll likely need a transplant.

By the time Ellie was transferred to Boston Children’s Hospital, at just a few weeks old, she already had the yellowed skin and eyes of jaundice — a sign of liver damage.

“And one day we were sitting at Children’s and a doctor knocked on the door and he came in and said, ‘My name is Dr. Mark Puder. I have something I’d like to talk to you about,'” Brogan remembered.

“And I approached the family,” Puder said, “because we had developed something in the laboratory that we’d already given to some patients and had reversed that liver injury.”

“He sat down and he told us that there were a little over 20 kids that they tried using fish oil with,” Brogan said, “and that in that limited number of kids they had seen great things with their livers — that the damage had not progressed, and in some cases it had cleared up.”

The Brogans agreed to be part of the trial. And it worked.

Read and listen to the full story at WGBH

Fish oil supplements help ease cancer treatment pain, study suggests

June 6, 2018 — Fish oil supplements may help alleviate the painful side effects of some cancer treatments, research suggests.

Two separate studies, presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago, show Omega-3 fatty acids can reduce discomfort caused by certain therapies.

The benefits were seen in some breast and bowel cancer patients, with the supplement thought to reduce inflammation.

Dr Andrew Epstein, speaking as an expert for ASCO, said: “It’s adding to the evidence base that nutritionally supplemental therapies like Omega-3 may have a place in supporting patients as they go through their cancer care.”

Around half of women taking aromatase inhibitors, a common drug for postmenopausal women with hormone receptor positive breast cancer, experience joint pain.

The hormone treatment is usually taken for between five to 10 years after surgery.

However an estimated 25% of patients stop within two years because they cannot endure the side effects, lead author Dr Sherry Shen, of the New York Presbyterian Hospital, said.

“This is a real problem, the joint pain,” she told the Press Association.

“And it’s really preventing women from taking these medications that are designed to prevent them getting a recurrence of their breast cancer.”

An analysis of a 2015 study of 249 patients found Omega-3 helped relieve symptoms among obese women taking the drug, who are more likely to experience joint pain.

Those with a BMI above 30 – around 140 patients – recorded an average “worst pain” score of seven out of 10 before taking the supplement or a placebo.

Read the full story at ITV